NervGen Pharma Corp. Common stock (NGEN) Financials

NGEN Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 63.6 million 51.4 million
March 31, 2026 14.9 million 10.9 million
Dec. 31, 2025 16.9 million 14.4 million
Sept. 30, 2025 9.4 million 11.5 million

NGEN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -4.1 million ?
March 31, 2026 -6.0 million ?
Dec. 31, 2025 -7.4 million 3.9 million
Sept. 30, 2025 -3.8 million 798862

NGEN Net Income

No data available :(

NGEN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 61.2 million - -
March 31, 2026 11.9 million - -
Dec. 31, 2025 16.1 million - 6104
Sept. 30, 2025 8.2 million - 23861

NGEN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 65.1 million
March 31, 2026 57.3 million
Dec. 31, 2025 52.8 million
Sept. 30, 2025 52.5 million

NGEN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 5.7 million 3.1 million -
March 31, 2026 2 3.5 million 1.9 million -
Dec. 31, 2025 - 4.8 million 3.8 million -
Sept. 30, 2025 - 3.2 million 1.2 million -

NGEN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - 10076
March 31, 2026 - 10169
Dec. 31, 2025 - -21846
Sept. 30, 2025 - 10031

NGEN

Price: $1.59

52 week price:
1.57
6.30

Earnings Per Share: -0.61 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 152.1 million

Links: